-
Product Insights
Micronics Japan – Aomori Factory No. 2 – Aomori
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micronics Japan - Aomori Factory No. 2 - Aomori report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Micron Technology – Boise Chip Manufacturing Plant – Idaho
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology - Boise Chip Manufacturing Plant - Idaho report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Micron Technology – Data Storage Devices Manufacturing Facility – Gujarat
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology - Data Storage Devices Manufacturing Facility - Gujarat report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Micron Technology – Manassas Semiconductor Manufacturing Facility Expansion – Virginia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology - Manassas Semiconductor Manufacturing Facility Expansion - Virginia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Micron Technology – Boise Solar Power Farm 40 MW – Idaho
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology - Boise Solar Power Farm 40 MW - Idaho report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Micron Technology – Yoshikawa Kogyo Danchi DRAM Chip Manufacturing Facility – Hiroshima
Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology - Yoshikawa Kogyo Danchi DRAM Chip Manufacturing Facility - Hiroshima report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Hana Micron – Bac Giang Hi-Tech and Semiconductor Device Factory – Bac Giang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hana Micron - Bac Giang Hi-Tech and Semiconductor Device Factory - Bac Giang report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Titan – Kulibin Micronized Silica Gels and Stable Silica Sols Production Plant – Nizjnij Novgorod
Equip yourself with the essential tools needed to make informed and profitable decisions with our Titan - Kulibin Micronized Silica Gels and Stable Silica Sols Production Plant - Nizjnij Novgorod report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Company Profile
![]()
Micron Technology Inc – Company Profile
Micron Technology Inc (Micron) is a manufacturer and provider of storage and memory products and solutions. The company’s product portfolio includes memory technologies, including dynamic random-access memory (DRAM), DRAM modules, managed NAND, ultra-bandwidth solutions, NAND flash, NOR flash, multichip packages, 3D XPoint memory, solid-state drives and memory cards. Micron serves networking, graphics, cloud server, enterprise, client, cloud, removable storage, smartphone, tablet, and device, automotive, industrial, and consumer electronics markets. The company sells its products under Micron and Crucial brand names....
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Palmidrol in Fibromyalgia (Fibromyalgia Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Palmidrol in Fibromyalgia (Fibromyalgia Syndrome) Drug Details: Palmidrol (FSD-201) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JNS-101 in Friedreich Ataxia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.JNS-101 in Friedreich AtaxiaDrug Details:JNS-101 is under development for the treatment of Friedreich’s ataxia. The drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TTAX-03 in Osteoarthritis Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TTAX-03 in Osteoarthritis Pain Drug Details:TTAX-03 is under development for the treatment of facet joint osteoarthritis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ReNu in Osteoarthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ReNu in OsteoarthritisDrug Details:ReNu is under development of the treatment of knee osteoarthritis (OA), hip osteoarthritis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ReNu in Fasciitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ReNu in FasciitisDrug Details:ReNu is under development of the treatment of knee osteoarthritis (OA), hip osteoarthritis...
-
Sector Analysis
Enterprise Storage Market Size, Trends, Drivers and Challenges, Vendor Landscape, Opportunities and Forecast to 2027
Enterprise Storage Market Research Report Overview The global enterprise storage market size was pegged at $123 billion in 2022. The market is expected to grow at a CAGR of more than 6% during the forecast period (2022-2027). Growing volumes of both structured and unstructured data generated by enterprises due to the increasing use of digital solutions like online & ecommerce platforms, enterprise mobility, connected devices, mobile apps, automation, and cloud, and the subsequent need to store such data for further...
-
Track & Monitor
New![]()
robotic process automation in Banking: automated PoS receipt printers
Innovation in the banking industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in banking industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Measles
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in MeaslesDrug Details:Vaccine candidate is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)Drug Details:Vaccine candidate is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QRA-244 in Amyotrophic Lateral Sclerosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QRA-244 in Amyotrophic Lateral Sclerosis Drug Details: QRA-244 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SOT-102 in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SOT-102 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:SON-102 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.